作者：
Georgina,Kingshott [1]
;
Kalina,Biernacka [1]
;
Alex,Sewell [2]
;
Paida,Gwiti [2]
;
Rachel,Barker [3]
;
Hanna,Zielinska [1]
;
Amanda,Gilkes [1]
;
Kathryn,McCarthy [4]
;
Richard M,Martin [5]
;
J Athene,Lane [6]
;
Lucy,McGeagh [7]
;
Anthony,Koupparis [8]
;
Edward,Rowe [9]
;
Jon,Oxley [10]
;
Jeff M P,Holly [10]
;
Claire M,Perks [2]
作者单位：
IGF & Metabolic Endocrinology Group, Translational Health Sciences, Bristol Medical School, Learning & Research Building, Southmead Hospital, Bristol BS10 5NB, UK.
[1]
Department of Cellular Pathology, North Bristol NHS Trust, Southmead Hospital, Bristol BS10 5NB, UK.
[2]
Department of Pathology, North West Anglia NHS Foundation Trust, Peterborough PE3 9GZ, UK.
[3]
Department of Haematology, Cardiff University, Heath Park, Cardiff CF14 4XN, UK.
[4]
Department of Surgery, Department of Medicine, Southmead Hospital, Bristol BS10 5NB, UK.
[5]
Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK.
[6]
National Institute for Health Research, Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Biomedical Research Unit Offices, University Hospitals Bristol Education Centre, Dental Hospital, Lower Maudlin Street, Bristol BS1 2LY, UK.
[7]
Bristol Randomised Trials Collaboration, Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK.
[8]
Supportive Cancer Care Research Group, Faculty of Health and Life Sciences, Oxford Institute of Nursing, Midwifery and Allied Health Research, Oxford Brookes University, Jack Straws Lane, Marston, Oxford OX3 0FL, UK.
[9]
Department of Urology, Bristol Urological Institute, Southmead Hospital, Bristol BS10 5NB, UK.
[10]
DOI
10.3390/cancers13040825
PMID
33669311
发布时间
2024-02-10
换一批
换一批
